Kite Pharma wasn’t expecting a regulatory decision for its non-Hodgkin lymphoma treatment until November, but this week, the company got the FDA’s O.K.
Eleven startups that spent the summer working in the Techstars Mobility accelerator program took to the stage to pitch their technologies to a packed house of investors, entrepreneurs, media, and other stakeholders at the Detroit Film Theatre Wednesday. According to Techstars,... Read more »
The conventional wisdom about Silicon Valley is that it’s a playground for the underdogs, a fertile ground for young entrepreneurs building startups that are going to “change the world.”
Instead, the Bay Area—while, yes, still home to thirsty young entrepreneurs—is increasingly... Read more »
General Electric’s push to remake itself as a software-focused industrial manufacturer took another step forward today with the announcement of a partnership with Silicon Valley giant Apple.
The companies are rolling out a software development kit that enables developers to create... Read more »
Vacation rental marketplace and management service Vacasa announced a $103.5 million Series B funding round, which the Portland, OR-based company says will help fund continued technology development and expansion to new markets.
In advance of an anticipated Senate hearing on drug prices, President Donald Trump once again denounced drug companies as “getting away with murder.” The first time he did so, using the same phrase just before his inauguration, the markets shuddered.... Read more »
LevelTen Energy, a Seattle startup making it easier for corporations to purchase renewable energy, has raised $6.8 million from investors.
Artificial intelligence—the catchall term for a broad swath of technologies imbuing computer systems with the capacity to perceive and act—is poised to upend industries across the economy. But nowhere is its promise more alluring than in healthcare, as the sweeping human... Read more »
As Amazon looks beyond Seattle for a large part of its future growth, Microsoft is stamping its legacy on the region’s foremost engine of the innovation economy, University of Washington.
The computer science department at the state’s flagship public research institution... Read more »
Blaze Bioscience, a Seattle-based biotech that’s developing “tumor paint” to help surgeons differentiate healthy tissue from tumors that should be removed, has raised a $16.1 million Series B-1 round of funding from existing investors, according a regulatory filing and the company’s... Read more »
In mid-October, eleven college students will be flying to California for an opportunity that would be the envy of any Ivy League MBA candidate—they’ll meet the venture capital firm partners who will personally mentor them throughout the school year.
The students—all... Read more »
Steve Case, venture capitalist, author, and co-founder of AOL, is preparing to hit the road this week on his sixth Rise of the Rest tour, where he travels to emerging innovation hubs in search of investment-worthy tech startups and to highlight... Read more »
The hype around artificial intelligence continues to inflate, even as technologies lumped under that broad and ill-defined heading begin to deliver real results. Meanwhile, there is a growing chorus asking technologists to proceed with caution—not so much because of fears stoked... Read more »
While I can understand professional video game playing, I was, until recently, baffled by the millions of avid fans of e-sports. I didn’t get why people—perhaps more than 300 million—would spend countless hours watching someone else manipulate the controls when they... Read more »
AltspaceVR, one of the forerunners of shared social experiences in virtual reality spaces, has been saved from extinction by Microsoft, which announced Tuesday that it is acquiring the four-year-old company.
The Redwood City, CA-based startup had sounded its own death knell... Read more »
Partner, PureTech Ventures
Chairman, CEO, Acucela
Partner, Voyager Capital
Founder, Seattle Biomedical Research Institute
Founder and Director, Pinwheel Diagnostics Inc.
President and Director, Fred Hutchinson Cancer Research Center
Professor of Bioengineering, University of Washington
Co-founder and CEO of ExtraHop Networks
Senior Advisor, Accelerator